Last reviewed · How we verify

NCT03514342

The Effects of Horner's Syndrome Developing After Interscalene Brachial Plexus Block on Autonomic Nervous Activity

Completed Last updated 18 June 2021
What this trial tests

trial testing Interscalene brachial plexus block in Brachial Plexus Block in 48 participants. Completed in 1 July 2019.

Timeline
18 June 2018
Primary endpoint
1 July 2019
1 July 2019

Quick facts

Lead sponsorDaegu Catholic University Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment48
Start date18 June 2018
Primary completion1 July 2019
Estimated completion1 July 2019
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Daegu Catholic University Medical Center

Who can join

Adults 20 to 60, any sex, with Brachial Plexus Block or Horner Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effects of Horner's syndrome on cardiac autonomic nervous activity after interscalene brachial plexus block. Cardiac autonomic nervous activity and bilateral pupil diameters will be measured in a scotopic light condition, 30 minutes after interscalene brachial plexus block under ultrasound guidance and 15 minutes after the subsequent sitting position.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Interscalene brachial plexus block

Trials testing the same drug.

Other Daegu Catholic University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03514342.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing